Price $3.48 |
Market Cap
351.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
7.16
|
P/S
0.79
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
43.4
|
Op. Cash Flow
13.6K
|
FCF
0.0
|
|
Op. Margin
-1.00%
|
Net Margin
-7.00%
|
ROE
-59.70%
|
ROI
-5.10%
|
|
ROA
-7.00%
|
EPS Growth
13.10%
|
Current Ratio
1.1
|
Debt/Equity
110.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.25 | - | - | 10.8M | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.05 | - | - | 21.8M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.82 | - | - | 38.5M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.60 | - | - | 64.9M | Strong Buy |
| Digirad Corporation (DRAD) | $1.87 | - | 13.30% | 33.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
